These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1399946)
41. In-vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae. Neal TJ; O'Donoghue MA; Ridgway EJ; Allen KD J Antimicrob Chemother; 1992 Jul; 30(1):39-46. PubMed ID: 1429335 [TBL] [Abstract][Full Text] [Related]
42. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. Walsh F; Carnegy F; Willcock J; Amyes S J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640 [TBL] [Abstract][Full Text] [Related]
43. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. Leclercq R; Nantas L; Soussy CJ; Duval J J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953 [TBL] [Abstract][Full Text] [Related]
44. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307 [TBL] [Abstract][Full Text] [Related]
45. [Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou]. Hua CZ; Shang SQ; Sun XF; Li JP; Chen ZM; Yu XL Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):16-9. PubMed ID: 14990098 [TBL] [Abstract][Full Text] [Related]
46. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics. Suzaki K Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168 [TBL] [Abstract][Full Text] [Related]
47. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology. Kays MB; Lisek CR; Denys GA Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118 [TBL] [Abstract][Full Text] [Related]
48. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany. Lemmen S; Al-Lahham A; Lütticken R; Reinert RR Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811 [TBL] [Abstract][Full Text] [Related]
49. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope]. Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861 [TBL] [Abstract][Full Text] [Related]
50. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. Dias R; Caniça M J Antimicrob Chemother; 2004 Dec; 54(6):1035-9. PubMed ID: 15531597 [TBL] [Abstract][Full Text] [Related]
51. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. Montanari MP; Mingoia M; Giovanetti E; Varaldo PE J Clin Microbiol; 2001 Apr; 39(4):1311-5. PubMed ID: 11283047 [TBL] [Abstract][Full Text] [Related]
52. [Activity of erythromycin and clarithromicin against isolates of Streptococcus pneumoniae with decreased sensitivity to penicillin obtained from healty carriers. Spanish Collaborative Group]. García de Lomas J; Gimeno C; Navarro D; Millás E; Bermejo M; Lázaro MA; Garijo B Enferm Infecc Microbiol Clin; 1996; 14(7):422-5. PubMed ID: 8991436 [TBL] [Abstract][Full Text] [Related]
53. [Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)]. Goldstein FW; Dang Van A; Bouanchaud DH; Acar JF Pathol Biol (Paris); 1978; 26(3-4):173-80. PubMed ID: 28505 [TBL] [Abstract][Full Text] [Related]
54. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs]. Mihajlović-Ukropina M; Milutinović M Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963 [TBL] [Abstract][Full Text] [Related]
55. The in-vitro activity of RP 59500 against gram-positive cocci. Goto S; Miyazaki S; Kaneko Y J Antimicrob Chemother; 1992 Jul; 30 Suppl A():25-8. PubMed ID: 1399947 [TBL] [Abstract][Full Text] [Related]